Skip to main content

Jeremy M. Sclar 2012 Irrevocable Family Trust's Form 4 filing

ProMIS Neurosciences Inc.PMN · filed Sep 30, 2025

Accession no.
0001104659-25-095035
Filed
Sep 30, 2025
Trade date
Jul 25-29, 2025
Filing delay
67 daysLate
Rule 10b5-1 plan
Not checked

This filing lists 3 non-derivative transactions and 4 derivative transactions. It was filed 67 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Jeremy M. Sclar 2012 Irrevocable Family TrustCIK 000208916310% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jul 25, 2025Common Shares, no par valueXIn-the-money exerciseAcquired+697,674–F1–2,315,111DirectDuplicate filing
Jul 25, 2025Common Shares, no par valueXIn-the-money exerciseAcquired+697,674–F2–3,012,785DirectDuplicate filing
Jul 25, 2025Common Shares, no par valueXIn-the-money exerciseAcquired+697,674–F3–3,710,459DirectDuplicate filing

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jul 25, 2025Common SharesXIn-the-money exerciseDisposed−697,674$0.00$00DirectDuplicate filing
Jul 25, 2025Common SharesXIn-the-money exerciseDisposed−697,674$0.00$00DirectDuplicate filing
Jul 25, 2025Common SharesXIn-the-money exerciseDisposed−697,674$0.00$00DirectDuplicate filing
Jul 29, 2025Common SharesPPurchaseAcquired+3,139,533–F4–3,139,533DirectDuplicate filing

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

On July 25, 2025, the Jeremy M. Sclar 2012 Irrevocable Family Trust (the "JS Trust") exercised 697,674 Tranche A purchase warrants, each exercisable to purchase one Common Share. These warrants were exercisable at an exercise price of $2.02 per warrant share; however, following an offer by the JS Trust and an acceptance by the Issuer, were exercised in full at an exercise price of $0.83518 per share.

Referenced by the price of 1 transaction in Table I.

F2

On July 25, 2025, the JS Trust exercised 697,674 Tranche B purchase warrants, each exercisable to purchase one Common Share. These warrants were exercisable at an exercise price of $2.02 per warrant share; however, following an offer by the JS Trust and an acceptance by the Issuer, were exercised in full at an exercise price of $0.83518 per share.

Referenced by the price of 1 transaction in Table I.

F3

On July 25, 2025, the JS Trust exercised 697,674 Tranche C purchase warrants, each exercisable to purchase one Common Share. These warrants were exercisable at an exercise price of $2.50 per warrant share; however, following an offer by the JS Trust and an acceptance by the Issuer, were exercised in full at an exercise price of $0.83518 per share.

Referenced by the price of 1 transaction in Table I.

F4

On July 29, 2025, the JS Trust acquired a warrant to purchase 3,139,533 Common Shares at an exercise price of $1.25 per share. The purchase price for the warrant was $0.1875 per Common Share underlying the warrant. The warrant is currently exercisable and expires five years after the date of issuance.

Referenced by the price of 1 transaction in Table II.

Read the full filing on SEC EDGAR (opens in a new tab)